Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

UniSector: - BioPharma

+ Add to Watchlist

UNISECB:LX

113.10 EUR 0.91 0.80%

As of 00:59:30 ET on 03/31/2015.

Snapshot for UniSector: - BioPharma (UNISECB)

Year To Date: +18.55% 3-Month: +18.55% 3-Year: +29.85% 52-Week Range: 74.99 - 116.50
1-Month: +3.82% 1-Year: +43.18% 5-Year: +19.86% Beta vs MSGUHC: 0.95

Mutual Fund Chart for UNISECB

No chart data available.
  • UNISECB:LX 113.10
  • 1M
  • 1Y
Interactive UNISECB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for UNISECB

UniSector: BioPharma is an open-end investment fund incorporated in Luxembourg. The Fund's objective is capital appreciation. The Fund invests at least two thirds of its assets in equities, convertible debentures, convertible bonds, bonds with warrants and other equity-related securities that are issued by companies in the pharmaceutical and biotechnology sectors worldwide.

Inception Date: 10-01-1999 Telephone: 352-264-08600
Managers: MARKUS MANNS
Web Site: www.union-investment.lu

Fundamentals for UNISECB

NAV (on 2015-03-31) 113.10
Assets (M) (on 2015-03-31) 295.03
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for UNISECB

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2013-11-14) 0.13
Dividend Yield (ttm) -

Fees & Expenses for UNISECB

Front Load 4.00
Back Load 0.00
Current Mgmt Fee 1.55
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.71

Top Fund Holdings for UNISECB

Filing Date: 09/30/2014
Name Position Value % of Total
Roche Holding AG 85,178 19,980,025 8.220%
Amgen Inc 170,565 18,967,271 7.803%
Sanofi 206,954 18,534,800 7.625%
Novartis AG 178,415 13,326,798 5.483%
Gilead Sciences Inc 149,000 12,557,240 5.166%
Johnson & Johnson 138,173 11,660,090 4.797%
Merck & Co Inc 245,000 11,498,377 4.730%
Celgene Corp 138,972 10,428,126 4.290%
Pfizer Inc 421,900 9,876,956 4.063%
GlaxoSmithKline PLC 521,171 9,453,333 3.889%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil